Addition of Enoxaparin to Neoadjuvant Chemoradiation of Esophageal Cancer

Condition:   Esophageal Neoplasms
Interventions:   Drug: enoxaparin (40 mg daily);   Radiation: control
Sponsor:   Mashhad University of Medical Sciences
Recruiting - verified August 2017

http://ift.tt/2fRGs2y